These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31848417)

  • 41. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
    Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
    Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human milk IgGs contain various combinations of different antigen-binding sites resulting in multiple variants of their bispecificity.
    Sedykh SE; Buneva VN; Nevinsky GA
    PLoS One; 2012; 7(8):e42942. PubMed ID: 22912765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc.
    Idusogie EE; Presta LG; Gazzano-Santoro H; Totpal K; Wong PY; Ultsch M; Meng YG; Mulkerrin MG
    J Immunol; 2000 Apr; 164(8):4178-84. PubMed ID: 10754313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variable region differences affect antibody binding to immobilized but not soluble antigen.
    Horgan C; Brown K; Pincus SH
    Hum Antibodies Hybridomas; 1992 Jul; 3(3):153-7. PubMed ID: 1391665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variation in N-linked carbohydrate chains in different batches of two chimeric monoclonal IgG1 antibodies produced by different murine SP2/0 transfectoma cell subclones.
    Bergwerff AA; Stroop CJ; Murray B; Holtorf AP; Pluschke G; Van Oostrum J; Kamerling JP; Vliegenthart JF
    Glycoconj J; 1995 Jun; 12(3):318-30. PubMed ID: 7496147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector.
    Kanda H; Mori K; Koga H; Taniguchi K; Kobayashi H; Sakahara H; Konishi J; Endo K; Watanabe T
    Hybridoma; 1994 Oct; 13(5):359-66. PubMed ID: 7860092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
    Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
    Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chimeric antibodies with anti-dextran-derived complementarity-determining regions and anti-p-azophenylarsonate-derived framework regions.
    Kao CY; Sharon J
    J Immunol; 1993 Aug; 151(4):1968-78. PubMed ID: 7688391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric and humanized antibodies with specificity for the CD33 antigen.
    Co MS; Avdalovic NM; Caron PC; Avdalovic MV; Scheinberg DA; Queen C
    J Immunol; 1992 Feb; 148(4):1149-54. PubMed ID: 1737932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preparation and biological activity analysis of chimeric antibody against capsular F1 antigen of Yersinia pestis].
    Zhang J; Ren J; Yu T; Song X; Fu G; Liu S; Zhang Z; Li B; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1299-302. PubMed ID: 24321075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation site.
    Leung SO; Dion AS; Pellegrini MC; Losman MJ; Grebenau RC; Goldenberg DM; Hansen HJ
    Int J Cancer; 1995 Feb; 60(4):534-8. PubMed ID: 7829269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
    Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of surface properties of human IgA, IgE, IgG and IgM antibodies with identical and different specificities.
    Wingren C; Michaelsen TE; Magnusson CG; Hansson UB
    Scand J Immunol; 1996 Nov; 44(5):430-6. PubMed ID: 8947593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multimerization is required for antigen binding activity of an engineered IgM/IgG chimeric antibody recognizing a skin-related antigen.
    Teye K; Hashimoto K; Numata S; Ohta K; Haftek M; Hashimoto T
    Sci Rep; 2017 Aug; 7(1):8212. PubMed ID: 28811604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.
    Hofer T; Tangkeangsirisin W; Kennedy MG; Mage RG; Raiker SJ; Venkatesh K; Lee H; Giger RJ; Rader C
    J Immunol Methods; 2007 Jan; 318(1-2):75-87. PubMed ID: 17140598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chicken anti-protein L for the detection of small amounts of protein L in the presence of IgG.
    Nilsson E; Larsson A
    Hybridoma (Larchmt); 2005 Apr; 24(2):112-4. PubMed ID: 15857176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.
    Tang Y; Lou J; Alpaugh RK; Robinson MK; Marks JD; Weiner LM
    J Immunol; 2007 Sep; 179(5):2815-23. PubMed ID: 17709495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional and pharmacokinetic properties of antibody-avidin fusion proteins.
    Shin SU; Wu D; Ramanathan R; Pardridge WM; Morrison SL
    J Immunol; 1997 May; 158(10):4797-804. PubMed ID: 9144494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration in H chain V region affects complement activation by chimeric antibodies.
    Horgan C; Brown K; Pincus SH
    J Immunol; 1990 Oct; 145(8):2527-32. PubMed ID: 2120333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.